 INCLUDED IN THIS ISSUE
 |
New Treatment for Advanced Kidney Cancer
Recent years have brought significant treatment advances for patients with advanced kidney cancer. However, even with a new class of targeted drugs known as signal transduction inhibitors, most patients' cancer will eventually continue to grow following either a preliminary period of disease stabilization or an initial positive response to treatment. A recent study led by Memorial Sloan-Kettering Cancer Center investigators has found that a new experimental targeted therapy known as everolimus can significantly delay cancer progression, giving this group of patients new hope. |
|
What's New at MSKCC.ORG
"The Changing Face of Breast Cancer: Where We Are, Where We Are Going, and How" Webcast
Watch as Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs at Memorial Sloan-Kettering Cancer Center, provides an overview of the latest advances in the prevention and treatment of breast cancer.
Acute Myelogenous Leukemia Overview Updated
Acute myeloid leukemia, or AML (also called acute myelogenous leukemia or acute nonlymphocytic leukemia), is a malignancy that arises in the white blood cells, which battle infectious agents throughout the body. In this newly expanded section, you can find information about symptoms, risk factors, diagnosis, treatment, and clinical trials, as well as our expertise in treating patients with AML.
New Critical Care Facility Enhances Treatment for Seriously Ill Patients
At Memorial Sloan-Kettering, critically ill patients are admitted to the Intensive Care Unit (ICU) to receive medical attention from highly trained physicians, nurses, and other skilled healthcare professionals.
Ralph Lauren Center Now Offers Colon Cancer Screening
The Ralph Lauren Center for Cancer Care and Prevention (RLCCCP) celebrated the opening of a 2,700-square-foot endoscopy wing that will make colon cancer screenings available to Harlem residents.
Research at Memorial Sloan-Kettering
Acupuncture Reduces Pain and Dysfunction in Head and Neck Cancer Patients after Neck Dissection
New data from a randomized, controlled trial found that acupuncture provided significant reductions in pain, dysfunction, and dry mouth in head and neck cancer patients after neck dissection.
Investigators Discover Immune Response to Prostate Cancer in Mice
Using mice that are genetically engineered to develop prostate cancer in a manner that mimics the formation of human prostate cancers, investigators at Memorial Sloan-Kettering Cancer Center have found a previously unknown immune response to tumor cells.
Survivorship Resources
New Survivorship Newsletter Launched
Bridges, Memorial Sloan-Kettering's newsletter for survivors written by survivors, is dedicated to our patients, each of whom has endured many hours of arduous treatment and all the other difficulties that follow a cancer diagnosis. The newsletter offers a forum where patients and their families can share stories of inspiration and hope, as well as the challenges that accompany the cancer survivor's journey.
Educational Program Web Casts
The following are Web casts of selected meetings, lectures, and discussions designed to assist in adjustment to life after cancer treatment. Each program is tailored to a specific aspect of living well after cancer. These programs are sponsored by our Post-Treatment Resource Program.
Cancer-Related Resources
About Herbs, Botanicals & Other Products
Presented by our Integrative Medicine Service, these pages provide evidence-based information about herbs, botanicals, supplements, and more.
65+ Social Work Program Events
Lectures sponsored by Memorial Sloan-Kettering's 65+ Social Work Program for patients 65 and older, as well as their family, friends, and caregivers.
Last Updated: Jun. 10, 2008
|
